Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin vs Isoniazid for Latent TB in Household Contacts
NCT01398618Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- May 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin in latent tuberculosis infection (LTBI), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
rifampicin
03
Conditions
latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on NCT01398618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01398618.